GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Mechanistic Dissection of the Fanconi Anemia Pathway of DNA Damage Response and R

$345,488
Patrick Sung · Yale University · R01 · FY2015 · CA

Targeting immune stroma interactions in pancreatic cancer

$345,477
Gregory B. Lesinski · Emory University · R01 · FY2021 · CA

Regulation of metastasis by alpha V integrin and Src

$345,453
David A Cheresh · University Of California, San Diego · R01 · FY2008 · CA

First in Human Trials of ProAgio, a Cytotoxin

$345,447
Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Regulation of Exocrine Pancreatic Progenitors by Ptf1a-p48

$345,434
Steven D Leach · Johns Hopkins University · R01 · FY2008 · DK

Pharmacological Ascorbate as a Radiosensitizer in Pancreatic Cancer

$345,413
Joseph J Cullen · University Of Iowa · R01 · FY2015 · CA

Whole Genome Scan for Pancreatic Cancer Risk in the Pancreatic Cancer Cohort Con

$345,369
Rachael Stolzenberg-Solomon · Cancer Epidemiology And Genetics · Z01 · FY2007 · CA

Evaluation of In Vivo Optical Imaging in Pancreatic and Ovarian Cancer Patients

$345,304
Lainie P Martin · Fox Chase Cancer Center · R01 · FY2011 · CA

Mechanisms of durable antitumor immunity via CD26hiCD4+ T cells

$345,257
Chrystal Mary Paulos · Medical University Of South Carolina · R01 · FY2017 · CA

Combination therapy with IFN expressing oncolytic adenovirus for pancreatic cancer

$345,230
Masato Yamamoto · University Of Minnesota · R01 · FY2022 · CA

Combination therapy with IFN expressing oncolytic adenovirus for pancreatic cancer

$345,230
Masato Yamamoto · University Of Minnesota · R01 · FY2023 · CA

Mechanistic Dissection of the Fanconi Anemia Pathway of DNA Damage Response and R

$345,229
Patrick Sung · Yale University · R01 · FY2013 · CA

Preclinical platform for theranostic nanoparticles in pancreatic cancer

$345,225
Nancy J Halas · Rice University · U01 · FY2012 · CA

Access of Therapeutic Agents to Cancer Cells

$345,202
Shibin Zhou · Johns Hopkins University · P50 · FY2015 · CA

New protein engineering-based tools and technologies for characterizing cell surface proteolysis in cancer cells for novel neo-epitope biomarkers and drug targets

$345,184
James A Wells · University Of California, San Francisco · R01 · FY2024 · CA

Exploring the Role of Mitochondrial Fission in Pancreatic Tumorigenesis

$345,180
David Francis Kashatus · University Of Virginia · R01 · FY2019 · CA

RTB 2

$345,016
Andrew Josef Ewald · Johns Hopkins University · U54 · FY2022 · CA

Regulation of Exocrine Pancreatic Progenitors by Ptf1a-p48

$345,015
Steven D Leach · Johns Hopkins University · R01 · FY2010 · DK

Cellular diversity and clinical relevance of stem cells in pancreatic cancer

$344,964
William H Matsui · Johns Hopkins University · R01 · FY2011 · CA

Clinical Translation of Nuclear Export Inhibitor in Metastatic Pancreatic Cancer

$344,871
Asfar S Azmi · Wayne State University · R37 · FY2023 · CA

Combination therapy to inhibit neuroblastoma growth

$344,838
Christopher Sumeet Babu Gondi · University Of Illinois At Chicago · R01 · FY2014 · CA

Dynamics of transmembrane dimers in TNF-Receptors by EPR and molecular simulation

$344,814
Jonathan N Sachs · University Of Minnesota · R01 · FY2014 · GM

Unique Anti-microbial Rinse to Reduce Oral Inflammation

$344,781
Charles J Gauntt · Biomedical Development Corporation · R44 · FY2009 · HL

Regulation of DNA replication kinetics by BRCA2 after DNA damage

$344,772
Bing Xia · Rbhs -Cancer Institute Of New Jersey · R01 · FY2021 · CA

Regulation of DNA replication kinetics by BRCA2 after DNA damage

$344,772
Bing Xia · Rutgers Biomedical And Health Sciences · R01 · FY2025 · CA